Industry Research Reports
Home > Reports > Pharma & Healthcare > Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Industry: Pharma & Healthcare
Published Date: 2024-04-16
Pages: 130 Pages
Report ld: 2687186
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Varicella Vaccine Market Size(US$)
CAGR 2024-2030
7.8%
Market Size,2030
USD 7,104.7
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 4,527.3 million
Market Forecast in 2030(Value)
US$ 7,104.7 million
CAGR
7.8%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
The global Varicella Vaccine market is projected to reach US$ 7104.7 million by 2030 from an estimated US$ 4527.3 million in 2024, at a CAGR of 7.8% during 2024 and 2030.
Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.
Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.
In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.
MARKET SEGMENTATION
By Company
- Merck
- GSK
- Shanghai Institute
- BCHT
- Changsheng
- Keygen
- Green Cross
- Biken
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Injection
- Freeze-Dried Powder
Segment by Application
- Kids Injection
- Adults Injection
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Varicella Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Varicella Vaccine.
The Varicella Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Varicella Vaccine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Varicella Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and regions.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Varicella Vaccine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Varicella Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Varicella Vaccine sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Varicella Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Varicella Vaccine Market Size Growth Rate by Type (2019 VS 2023 VS 2030)
1.2.2 Injection
1.2.3 Freeze-Dried Powder
1.3 Market by Application
1.3.1 Global Varicella Vaccine Market Size Growth Rate by Application (2019 VS 2023 VS 2030)
1.3.2 Kids Injection
1.3.3 Adults Injection
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Varicella Vaccine Market Size Estimates and Forecasts
2.1.1 Global Varicella Vaccine Revenue 2019-2030
2.1.2 Global Varicella Vaccine Sales 2019-2030
2.2 Varicella Vaccine Market Size by Region: 2023 Versus 2030
2.3 Varicella Vaccine Sales by Region (2019-2030)
2.3.1 Global Varicella Vaccine Sales by Region: 2019-2024
2.3.2 Global Varicella Vaccine Sales Forecast by Region (2025-2030)
2.3.3 Global Varicella Vaccine Sales Market Share by Region (2019-2030)
2.4 Varicella Vaccine Market Estimates and Projections by Region (2025-2030)
2.4.1 Global Varicella Vaccine Revenue by Region: 2019-2024
2.4.2 Global Varicella Vaccine Revenue Forecast by Region (2025-2030)
2.4.3 Global Varicella Vaccine Revenue Market Share by Region (2019-2030)
3 Global Varicella Vaccine by Manufacturers
3.1 Global Top Varicella Vaccine Manufacturers by Sales
3.1.1 Global Varicella Vaccine Sales by Manufacturer (2019-2024)
3.1.2 Global Varicella Vaccine Sales Market Share by Manufacturer (2019-2024)
3.2 Global Top Varicella Vaccine Manufacturers by Revenue
3.2.1 Global Varicella Vaccine Revenue by Manufacturer (2019-2024)
3.2.2 Global Varicella Vaccine Revenue Share by Manufacturer (2019-2024)
3.3 Global Varicella Vaccine Price by Manufacturer (2019-2024)
3.4 Competitive Landscape
3.4.1 Key Varicella Vaccine Manufacturers Covered: Ranking by Revenue
3.4.2 Global Varicella Vaccine Market Concentration Ratio (CR5 and HHI) & (2019-2024)
3.4.3 Global Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Varicella Vaccine Manufacturing Base Distribution, Product Type
3.5.1 Varicella Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Varicella Vaccine Product Type
3.5.3 Date of International Manufacturers Enter into Varicella Vaccine Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Merck
4.1.1 Merck Company Information
4.1.2 Merck Description, Business Overview
4.1.3 Merck Varicella Vaccine Products Offered
4.1.4 Merck Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.1.5 Merck Varicella Vaccine Sales by Product in 2023
4.1.6 Merck Varicella Vaccine Sales by Application in 2023
4.1.7 Merck Varicella Vaccine Sales by Geographic Area in 2023
4.1.8 Merck Recent Developments
4.2 GSK
4.2.1 GSK Company Information
4.2.2 GSK Description, Business Overview
4.2.3 GSK Varicella Vaccine Products Offered
4.2.4 GSK Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.2.5 GSK Varicella Vaccine Sales by Product in 2023
4.2.6 GSK Varicella Vaccine Sales by Application in 2023
4.2.7 GSK Varicella Vaccine Sales by Geographic Area in 2023
4.2.8 GSK Recent Developments
4.3 Shanghai Institute
4.3.1 Shanghai Institute Company Information
4.3.2 Shanghai Institute Description, Business Overview
4.3.3 Shanghai Institute Varicella Vaccine Products Offered
4.3.4 Shanghai Institute Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.3.5 Shanghai Institute Varicella Vaccine Sales by Product in 2023
4.3.6 Shanghai Institute Varicella Vaccine Sales by Application in 2023
4.3.7 Shanghai Institute Varicella Vaccine Sales by Geographic Area in 2023
4.3.8 Shanghai Institute Recent Developments
4.4 BCHT
4.4.1 BCHT Company Information
4.4.2 BCHT Description, Business Overview
4.4.3 BCHT Varicella Vaccine Products Offered
4.4.4 BCHT Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.4.5 BCHT Varicella Vaccine Sales by Product in 2023
4.4.6 BCHT Varicella Vaccine Sales by Application in 2023
4.4.7 BCHT Varicella Vaccine Sales by Geographic Area in 2023
4.4.8 BCHT Recent Developments
4.5 Changsheng
4.5.1 Changsheng Company Information
4.5.2 Changsheng Description, Business Overview
4.5.3 Changsheng Varicella Vaccine Products Offered
4.5.4 Changsheng Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.5.5 Changsheng Varicella Vaccine Sales by Product in 2023
4.5.6 Changsheng Varicella Vaccine Sales by Application in 2023
4.5.7 Changsheng Varicella Vaccine Sales by Geographic Area in 2023
4.5.8 Changsheng Recent Developments
4.6 Keygen
4.6.1 Keygen Company Information
4.6.2 Keygen Description, Business Overview
4.6.3 Keygen Varicella Vaccine Products Offered
4.6.4 Keygen Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.6.5 Keygen Varicella Vaccine Sales by Product in 2023
4.6.6 Keygen Varicella Vaccine Sales by Application in 2023
4.6.7 Keygen Varicella Vaccine Sales by Geographic Area in 2023
4.6.8 Keygen Recent Development
4.7 Green Cross
4.7.1 Green Cross Company Information
4.7.2 Green Cross Description, Business Overview
4.7.3 Green Cross Varicella Vaccine Products Offered
4.7.4 Green Cross Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.7.5 Green Cross Varicella Vaccine Sales by Product in 2023
4.7.6 Green Cross Varicella Vaccine Sales by Application in 2023
4.7.7 Green Cross Varicella Vaccine Sales by Geographic Area in 2023
4.7.8 Green Cross Recent Development
4.8 Biken
4.8.1 Biken Company Information
4.8.2 Biken Description, Business Overview
4.8.3 Biken Varicella Vaccine Products Offered
4.8.4 Biken Varicella Vaccine Sales, Revenue and Gross Margin (2019-2024)
4.8.5 Biken Varicella Vaccine Sales by Product in 2023
4.8.6 Biken Varicella Vaccine Sales by Application in 2023
4.8.7 Biken Varicella Vaccine Sales by Geographic Area in 2023
4.8.8 Biken Recent Development
5 Breakdown Data by Type
5.1 Global Varicella Vaccine Sales by Type (2019-2030)
5.1.1 Global Varicella Vaccine Sales by Type (2019-2024)
5.1.2 Global Varicella Vaccine Sales Forecast by Type (2025-2030)
5.1.3 Global Varicella Vaccine Sales Market Share by Type (2019-2030)
5.2 Global Varicella Vaccine Revenue Forecast by Type (2019-2030)
5.2.1 Global Varicella Vaccine Revenue by Type (2019-2024)
5.2.2 Global Varicella Vaccine Revenue Forecast by Type (2025-2030)
5.2.3 Global Varicella Vaccine Revenue Market Share by Type (2019-2030)
5.3 Varicella Vaccine Average Selling Price (ASP) by Type (2019-2030)
6 Breakdown Data by Application
6.1 Global Varicella Vaccine Sales by Application (2019-2030)
6.1.1 Global Varicella Vaccine Sales by Application (2019-2024)
6.1.2 Global Varicella Vaccine Sales Forecast by Application (2025-2030)
6.1.3 Global Varicella Vaccine Sales Market Share by Application (2019-2030)
6.2 Global Varicella Vaccine Revenue Forecast by Application (2019-2030)
6.2.1 Global Varicella Vaccine Revenue by Application (2019-2024)
6.2.2 Global Varicella Vaccine Revenue Forecast by Application (2025-2030)
6.2.3 Global Varicella Vaccine Revenue Market Share by Application (2019-2030)
6.3 Varicella Vaccine Average Selling Price (ASP) by Application (2019-2030)
7 North America
7.1 North America Varicella Vaccine Market Size YoY Growth 2019-2030
7.2 North America Varicella Vaccine Market Facts & Figures by Country
7.2.1 North America Varicella Vaccine Sales by Country (2019-2030)
7.2.2 North America Varicella Vaccine Revenue by Country (2019-2030)
7.3 North America Varicella Vaccine Sales by Type (2019-2024)
7.4 North America Varicella Vaccine Sales by Application (2019-2024)
8 Asia-Pacific
8.1 Asia-Pacific Varicella Vaccine Market Size YoY Growth 2019-2030
8.2 Asia-Pacific Varicella Vaccine Market Facts & Figures by Region
8.2.1 Asia-Pacific Varicella Vaccine Sales by Region (2019-2030)
8.2.2 Asia-Pacific Varicella Vaccine Revenue by Region (2019-2030)
8.3 Asia-Pacific Varicella Vaccine Sales by Type (2019-2024)
8.4 Asia-Pacific Varicella Vaccine Sales by Application (2019-2024)
9 Europe
9.1 Europe Varicella Vaccine Market Size YoY Growth 2019-2030
9.2 Europe Varicella Vaccine Market Facts & Figures by Country
9.2.1 Europe Varicella Vaccine Sales by Country (2019-2030)
9.2.2 Europe Varicella Vaccine Revenue by Country (2019-2030)
9.3 Europe Varicella Vaccine Sales by Type (2019-2024)
9.4 Europe Varicella Vaccine Sales by Application (2019-2024)
10 Latin America
10.1 Latin America Varicella Vaccine Market Size YoY Growth 2019-2030
10.2 Latin America Varicella Vaccine Market Facts & Figures by Country
10.2.1 Latin America Varicella Vaccine Sales by Country (2019-2030)
10.2.2 Latin America Varicella Vaccine Revenue by Country (2019-2030)
10.3 Latin America Varicella Vaccine Sales by Type (2019-2024)
10.4 Latin America Varicella Vaccine Sales by Application (2019-2024)
11 Middle East and Africa
11.1 Middle East and Africa Varicella Vaccine Market Size YoY Growth 2019-2030
11.2 Middle East and Africa Varicella Vaccine Market Facts & Figures by Country
11.2.1 Middle East and Africa Varicella Vaccine Sales by Country (2019-2030)
11.2.2 Middle East and Africa Varicella Vaccine Revenue by Country (2019-2030)
11.3 Middle East and Africa Varicella Vaccine Sales by Type (2019-2024)
11.4 Middle East and Africa Varicella Vaccine Sales by Application (2019-2024)
12 Supply Chain and Sales Channel Analysis
12.1 Varicella Vaccine Supply Chain Analysis
12.2 Varicella Vaccine Key Raw Materials and Upstream Suppliers
12.3 Varicella Vaccine Clients Analysis
12.4 Varicella Vaccine Sales Channel and Sales Model Analysis
12.4.1 Varicella Vaccine Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Varicella Vaccine Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Varicella Vaccine Distributors
13 Market Dynamics
13.1 Varicella Vaccine Industry Trends
13.2 Varicella Vaccine Market Drivers
13.3 Varicella Vaccine Market Challenges
13.4 Varicella Vaccine Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Varicella Vaccine Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Major Manufacturers of Injection
Table 3. Major Manufacturers of Freeze-Dried Powder
Table 4. Global Varicella Vaccine Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Varicella Vaccine Market Size by Region (US$ Million): 2023 VS 2030
Table 6. Global Varicella Vaccine Sales by Region (2019-2024) & (M Doses)
Table 7. Global Varicella Vaccine Sales Forecast by Region (2025-2030) & (M Doses)
Table 8. Global Varicella Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 9. Global Varicella Vaccine Revenue Forecast by Region (2025-2030) & (US$ Million)
Table 10. Global Varicella Vaccine Sales by Manufacturer (2019-2024) & (M Doses)
Table 11. Global Varicella Vaccine Sales Share by Manufacturer (2019-2024)
Table 12. Varicella Vaccine Revenue by Manufacturer (2019-2024) & (US$ Million)
Table 13. Varicella Vaccine Revenue Share by Manufacturer (2019-2024)
Table 14. Key Manufacturers Varicella Vaccine Price (2019-2024) & (USD/Dose)
Table 15. Ranking of Global Top Varicella Vaccine Manufacturers by Revenue (US$ Million) in 2023
Table 16. Global Varicella Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2019-2024)
Table 17. Global Varicella Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Varicella Vaccine as of 2023)
Table 18. Varicella Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Varicella Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Varicella Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Merck Company Information
Table 23. Merck Description and Business Overview
Table 24. Merck Varicella Vaccine Product
Table 25. Merck Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 26. Merck Sales Proportion of Varicella Vaccine by Product in 2023
Table 27. Merck Sales Proportion of Varicella Vaccine by Application in 2023
Table 28. Merck Sales Proportion of Varicella Vaccine by Geographic Area in 2023
Table 29. Merck Recent Development
Table 30. GSK Company Information
Table 31. GSK Description and Business Overview
Table 32. GSK Varicella Vaccine Product
Table 33. GSK Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 34. GSK Sales Proportion of Varicella Vaccine by Product in 2023
Table 35. GSK Sales Proportion of Varicella Vaccine by Application in 2023
Table 36. GSK Sales Proportion of Varicella Vaccine by Geographic Area in 2023
Table 37. GSK Recent Development
Table 38. Shanghai Institute Company Information
Table 39. Shanghai Institute Description and Business Overview
Table 40. Shanghai Institute Varicella Vaccine Product
Table 41. Shanghai Institute Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 42. Shanghai Institute Sales Proportion of Varicella Vaccine by Product in 2023
Table 43. Shanghai Institute Sales Proportion of Varicella Vaccine by Application in 2023
Table 44. Shanghai Institute Sales Proportion of Varicella Vaccine by Geographic Area in 2023
Table 45. Shanghai Institute Recent Development
Table 46. BCHT Company Information
Table 47. BCHT Description and Business Overview
Table 48. BCHT Varicella Vaccine Product
Table 49. BCHT Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 50. BCHT Sales Proportion of Varicella Vaccine by Product in 2023
Table 51. BCHT Sales Proportion of Varicella Vaccine by Application in 2023
Table 52. BCHT Sales Proportion of Varicella Vaccine by Geographic Area in 2023
Table 53. BCHT Recent Development
Table 54. Changsheng Company Information
Table 55. Changsheng Description and Business Overview
Table 56. Changsheng Varicella Vaccine Product
Table 57. Changsheng Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 58. Changsheng Sales Proportion of Varicella Vaccine by Product in 2023
Table 59. Changsheng Sales Proportion of Varicella Vaccine by Application in 2023
Table 60. Changsheng Sales Proportion of Varicella Vaccine by Geographic Area in 2023
Table 61. Changsheng Recent Development
Table 62. Keygen Company Information
Table 63. Keygen Description and Business Overview
Table 64. Keygen Varicella Vaccine Product
Table 65. Keygen Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 66. Keygen Sales Proportion of Varicella Vaccine by Product in 2023
Table 67. Keygen Sales Proportion of Varicella Vaccine by Application in 2023
Table 68. Keygen Sales Proportion of Varicella Vaccine by Geographic Area in 2023
Table 69. Keygen Recent Development
Table 70. Green Cross Company Information
Table 71. Green Cross Description and Business Overview
Table 72. Green Cross Varicella Vaccine Product
Table 73. Green Cross Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 74. Green Cross Sales Proportion of Varicella Vaccine by Product in 2023
Table 75. Green Cross Sales Proportion of Varicella Vaccine by Application in 2023
Table 76. Green Cross Sales Proportion of Varicella Vaccine by Geographic Area in 2023
Table 77. Green Cross Recent Development
Table 78. Biken Company Information
Table 79. Biken Description and Business Overview
Table 80. Biken Varicella Vaccine Product
Table 81. Biken Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 82. Biken Sales Proportion of Varicella Vaccine by Product in 2023
Table 83. Biken Sales Proportion of Varicella Vaccine by Application in 2023
Table 84. Biken Sales Proportion of Varicella Vaccine by Geographic Area in 2023
Table 85. Biken Recent Development
Table 86. Global Varicella Vaccine Sales by Type (2019-2024) & (M Doses)
Table 87. Global Varicella Vaccine Sales Forecast by Type (2025-2030) & (M Doses)
Table 88. Global Varicella Vaccine Revenue by Type (2019-2024) & (US$ Million)
Table 89. Global Varicella Vaccine Revenue Forecast by Type (2025-2030) & (US$ Million)
Table 90. Global Varicella Vaccine Sales by Application (2019-2024) & (M Doses)
Table 91. Global Varicella Vaccine Sales Forecast by Application (2025-2030) & (M Doses)
Table 92. Global Varicella Vaccine Revenue by Application (2019-2024) & (US$ Million)
Table 93. Global Varicella Vaccine Revenue Forecast by Application (2025-2030) & (US$ Million)
Table 94. North America Varicella Vaccine Sales by Country (2019-2024) & (M Doses)
Table 95. North America Varicella Vaccine Sales by Country (2025-2030) & (M Doses)
Table 96. North America Varicella Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 97. North America Varicella Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 98. North America Varicella Vaccine Sales by Type (2019-2024) & (M Doses)
Table 99. North America Varicella Vaccine Sales by Application (2019-2024) & (M Doses)
Table 100. Asia-Pacific Varicella Vaccine Sales by Region (2019-2024) & (M Doses)
Table 101. Asia-Pacific Varicella Vaccine Sales by Region (2025-2030) & (M Doses)
Table 102. Asia-Pacific Varicella Vaccine Revenue by Region (2019-2030) & (US$ Million)
Table 103. Asia-Pacific Varicella Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 104. Asia-Pacific Varicella Vaccine Sales by Type (2019-2024) & (M Doses)
Table 105. Asia-Pacific Varicella Vaccine Sales by Application (2019-2024) & (M Doses)
Table 106. Europe Varicella Vaccine Sales by Country (2019-2024) & (M Doses)
Table 107. Europe Varicella Vaccine Sales by Country (2025-2030) & (M Doses)
Table 108. Europe Varicella Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 109. Europe Varicella Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 110. Europe Varicella Vaccine Sales by Type (2019-2024) & (M Doses)
Table 111. Europe Varicella Vaccine Sales by Application (2019-2024) & (M Doses)
Table 112. Latin America Varicella Vaccine Sales by Country (2019-2024) & (M Doses)
Table 113. Latin America Varicella Vaccine Sales by Country (2025-2030) & (M Doses)
Table 114. Latin America Varicella Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 115. Latin America Varicella Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 116. Latin America Varicella Vaccine Sales by Type (2019-2024) & (M Doses)
Table 117. Latin America Varicella Vaccine Sales by Application (2019-2024) & (M Doses)
Table 118. Middle East and Africa Varicella Vaccine Sales by Country (2019-2024) & (M Doses)
Table 119. Middle East and Africa Varicella Vaccine Sales by Country (2025-2030) & (M Doses)
Table 120. Middle East and Africa Varicella Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 121. Middle East and Africa Varicella Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 122. Middle East and Africa Varicella Vaccine Sales by Type (2019-2024) & (M Doses)
Table 123. Middle East and Africa Varicella Vaccine Sales by Application (2019-2024) & (M Doses)
Table 124. Varicella Vaccine Key Raw Materials, Industry Status and Trend
Table 125. Varicella Vaccine Key Raw Materials and Upstream Suppliers
Table 126. Varicella Vaccine Clients Status and Trend
Table 127. Varicella Vaccine Typical Clients
Table 128. Varicella Vaccine Distributors
Table 129. Varicella Vaccine Market Trends
Table 130. Varicella Vaccine Market Drivers
Table 131. Varicella Vaccine Market Challenges
Table 132. Varicella Vaccine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Varicella Vaccine Product Picture
Figure 2. Global Varicella Vaccine Sales Market Share by Type in 2023 & 2030
Figure 3. Injection Product Picture
Figure 4. Freeze-Dried Powder Product Picture
Figure 5. Global Varicella Vaccine Sales Market Share by Application in 2023 & 2030
Figure 6. Kids Injection Examples
Figure 7. Adults Injection Examples
Figure 8. Varicella Vaccine Report Years Considered
Figure 9. Global Varicella Vaccine Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 10. Global Varicella Vaccine Market Size 2019-2030 (US$ Million)
Figure 11. Global Varicella Vaccine Sales 2019-2030 (M Doses)
Figure 12. Global Varicella Vaccine Sales Market Share Forecast by Region (2019-2030)
Figure 13. Global Varicella Vaccine Revenue Market Share by Region (2019-2030)
Figure 14. Global Varicella Vaccine Sales Share by Manufacturer in 2023
Figure 15. Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 16. Global Varicella Vaccine Sales Market Share Forecast by Type (2019-2030)
Figure 17. Global Varicella Vaccine Revenue Market Share Forecast by Type (2019-2030)
Figure 18. Varicella Vaccine Average Selling Price (ASP) by Type (2019-2024) & (USD/Dose)
Figure 19. Global Varicella Vaccine Sales Market Share Forecast by Application (2019-2030)
Figure 20. Global Varicella Vaccine Revenue Market Share Forecast by Application (2019-2030)
Figure 21. Varicella Vaccine Average Selling Price (ASP) by Application (2019-2024) & (USD/Dose)
Figure 22. North America Varicella Vaccine Revenue 2019-2030 (US$ Million)
Figure 23. North America Varicella Vaccine Sales Market Share by Type (2019-2024)
Figure 24. North America Varicella Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Asia-Pacific Varicella Vaccine Revenue 2019-2030 (US$ Million)
Figure 26. Asia-Pacific Varicella Vaccine Sales Market Share by Region (2019-2030)
Figure 27. Asia-Pacific Varicella Vaccine Revenue Market Share by Region (2019-2030)
Figure 28. Asia-Pacific Varicella Vaccine Sales Market Share by Type (2019-2024)
Figure 29. Asia-Pacific Varicella Vaccine Sales Market Share by Application (2019-2024)
Figure 30. Europe Varicella Vaccine Revenue Growth Rate 2019-2030 (US$ Million)
Figure 31. Europe Varicella Vaccine Sales Market Share by Country (2019-2030)
Figure 32. Europe Varicella Vaccine Revenue Market Share by Country (2019-2030)
Figure 33. Europe Varicella Vaccine Sales Market Share by Type (2019-2024)
Figure 34. Europe Varicella Vaccine Sales Market Share by Application (2019-2024)
Figure 35. Latin America Varicella Vaccine Revenue Growth Rate 2019-2030 (US$ Million)
Figure 36. Latin America Varicella Vaccine Sales Market Share by Country (2019-2030)
Figure 37. Latin America Varicella Vaccine Revenue Market Share by Country (2019-2024)
Figure 38. Latin America Varicella Vaccine Sales Market Share by Type (2019-2024)
Figure 39. Latin America Varicella Vaccine Sales Market Share by Application (2019-2024)
Figure 40. Middle East and Africa Varicella Vaccine Revenue Growth Rate 2019-2030 (US$ Million)
Figure 41. Middle East and Africa Varicella Vaccine Sales Market Share by Country (2019-2030)
Figure 42. Middle East and Africa Varicella Vaccine Revenue Market Share by Country (2019-2030)
Figure 43. Middle East and Africa Varicella Vaccine Sales Market Share by Type (2019-2024)
Figure 44. Middle East and Africa Varicella Vaccine Sales Market Share by Application (2019-2024)
Figure 45. Varicella Vaccine Supply Chain (Upstream and Downstream Market)
Figure 46. Global Production Market Share of Varicella Vaccine Raw Materials by Region in 2023
Figure 47. Varicella Vaccine Distribution Channels
Figure 48. Global Varicella Vaccine Percentage 2019-2030: Indirect Sales VS Direct Sales
Figure 49. Global Varicella Vaccine Percentage 2019-2030: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Varicella Vaccine in 2030?
The global market size of Varicella Vaccine in 2030 was 7104.7 Million USD.
What was the global market size of Varicella Vaccine in 2024?
What is the annual compound growth rate of the global Varicella Vaccine market size from 2024 to 2030?
Which companies rank high in the global Varicella Vaccine market?
Which region is expected to have the highest market share?
Related Reports
Global Varicella Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Varicella Vaccine market size was US$ 5185 million in 2025 and is forecast to reach a readjusted size of US$ 8708 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 79
USD 4250.00
(Single User License)
Global Varicella Vaccine Market Research Report 2026
The global Varicella Vaccine market was valued at US$ 5185 million in 2025 and is anticipated to reach US$ 8708 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 114
USD 2900.00
(Single User License)
Varicella Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Varicella Vaccine was estimated to be worth US$ 5185 million in 2025 and is projected to reach US$ 8708 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 96
USD 3950.00
(Single User License)
Global Varicella Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Varicella Vaccine market is projected to grow from US$ 4845 million in 2024 to US$ 8137 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 149
USD 4900.00
(Single User License)
Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Varicella Vaccine was estimated to be worth US$ 4845 million and is forecast to reach approximately US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 135
USD 5900.00
(Single User License)
Global Varicella Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Varicella Vaccine market size was US$ 4845 million in 2024 and is forecast to a readjusted size of US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 77
USD 4250.00
(Single User License)
Varicella Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Varicella Vaccine was estimated to be worth US$ 4845 million in 2024 and is forecast to a readjusted size of US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 95
USD 3950.00
(Single User License)
Global Varicella Vaccine Market Research Report 2025
The global market for Varicella Vaccine was valued at US$ 4845 million in the year 2024 and is projected to reach a revised size of US$ 8137 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published Date: 2025-01-16
Pages: 80
USD 2900.00
(Single User License)
Global Varicella Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Published Date: 2024-04-17
Pages: 140
USD 5600.00
(Single User License)
Global Varicella Vaccine Market Insights, Forecast to 2030
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Published Date: 2024-04-07
Pages: 87
USD 4900.00
(Single User License)
Global Varicella Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Varicella Vaccine market size was US$ 5185 million in 2025 and is forecast to reach a readjusted size of US$ 8708 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 79
USD 4250.00 (Single User License)Global Varicella Vaccine Market Research Report 2026
The global Varicella Vaccine market was valued at US$ 5185 million in 2025 and is anticipated to reach US$ 8708 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 114
USD 2900.00 (Single User License)Varicella Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Varicella Vaccine was estimated to be worth US$ 5185 million in 2025 and is projected to reach US$ 8708 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 96
USD 3950.00 (Single User License)Global Varicella Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Varicella Vaccine market is projected to grow from US$ 4845 million in 2024 to US$ 8137 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 149
USD 4900.00 (Single User License)Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Varicella Vaccine was estimated to be worth US$ 4845 million and is forecast to reach approximately US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 135
USD 5900.00 (Single User License)Global Varicella Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Varicella Vaccine market size was US$ 4845 million in 2024 and is forecast to a readjusted size of US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 77
USD 4250.00 (Single User License)Varicella Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Varicella Vaccine was estimated to be worth US$ 4845 million in 2024 and is forecast to a readjusted size of US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 95
USD 3950.00 (Single User License)Global Varicella Vaccine Market Research Report 2025
The global market for Varicella Vaccine was valued at US$ 4845 million in the year 2024 and is projected to reach a revised size of US$ 8137 million by 2031, growing at a CAGR of 7.8% during the forecast period.
Published: 2025-01-16
Pages: 80
USD 2900.00 (Single User License)Global Varicella Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Published: 2024-04-17
Pages: 140
USD 5600.00 (Single User License)Global Varicella Vaccine Market Insights, Forecast to 2030
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Published: 2024-04-07
Pages: 87
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5900.00
USD 8850.00
USD 11800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now